Looking for Her2 Positive survivor stories

Options
1303132333436»

Comments

  • Margun
    Margun Member Posts: 419
    edited January 2022

    I had herceptin. I have no success registering it in my profile.

    According to the table, after 5 years the recurrence is only 2 percent for early stagers

  • Beesie
    Beesie Member Posts: 12,240
    edited January 2022

    I'm not HER2+ but I saw this discussion in the Active List and thought that I'd pop in and add this graph. It's important to note that this wasn't a large study but it does address the recent questions in terms of risk of recurrence after 5 years for HER2+ patients.

    image

    Source: https://wjso.biomedcentral.com/articles/10.1186/s1...


  • MCBaker
    MCBaker Member Posts: 1,555
    edited January 2022

    Yes, small sample, and no breakdown of what stage de novo.


  • SpecialK
    SpecialK Member Posts: 16,486
    edited January 2022

    Just wanted to add that the general consensus is that Her2+ driven recurrence usually happens in the first 2-3 years post treatment, if those with recurrence are years out it is possibly more likely to be driven by the hormonal aspect. I think this study has good generalized info, but there are several things to note. This study was looking at patients from 2005-2013. It appears that in the text between Table 4 and Fig 1, 92% of the Her2+ patients did not receive adjuvent Herceptin. Since this study was looking at a timeframe earlier than 2013, Perjeta would not have been prescribed yet and neoadjuvent systemic treatment was unlikely. Kadcyla for residual disease in larger tumors, node positives, or high risk patients would certainly not have been given. The unfortunate thing about studies is that they are often looking at data collected earlier than the use of current treatment regimens that have now become standard of care, so there is some degree of lag. As is pointed out at the end of the discussion in the study, if you are having any treatment that is different from what was studied it makes it a bit harder to apply these stats to those being treated now or in the recent past. In a subtype like Her2+ disease, that has a rapidly changing treatment environment, it can be a challenge to interpret and apply info!

  • DeniseML
    DeniseML Member Posts: 81
    edited January 2022

    Thank-you Raliegh girl for your post. it is up-lifting and encouraging to hear your story since I, too had IDC, 2 large tumors - 6 cm. combined, many, many lymph nodes involved, ER- HER2+, same chemo and targeted therapy with pCR. I did have inflammatory BC also. I am 18 months out of initial diagnosis and 7 months out from end of all treatment.

    I thought I had read something about highest risk for our scenario was first 5 years, first 2 being the highest incidents of recurrence. I try not to dwell on risks .

    wishing all the best of luck and happiest life has to offer!

  • Spudsie
    Spudsie Member Posts: 1
    edited March 2022

    HER2 3C on diagnosis Aug 2015, (12/36 nodes positive and removed) Double Mastectomy in Oct 2015. This was followed with Chemo + Herceptin. Didn't go through with radiotherapy. Implants in at the mastectomy. Had them out 6 months later. I hated them. It's been 6 1/2 years now. I honestly don't even really think about it until a mate gets Breast cancer and wants to talk about their options.

  • moth
    moth Member Posts: 4,800
    edited March 2022

    "HER2-positive breast cancer progressively turned from the most feared to the most curable subtype.

    Currently, more than 9 out of 10 patients with HER2-positive breast cancer who are treated with chemotherapy and HER2-blockade are free from recurrence 6 years after surgery.3 The treatment and outcomes of HER2-positive breast cancer have improved so much that the research focus has gradually shifted from treatment escalation toward a search for safe de-escalation opportunities."

    More Tolerable Cures for Patients With Early-Stage HER2-Positive Breast Cancer: Halfway to Precision March 2022

    https://dailynews.ascopubs.org/do/10.1200/ADN.22.2...


  • Melbo
    Melbo Member Posts: 346
    edited March 2022

    thanks for sharing Moth! That is very heartening news, especially for hormone negative folks. Now I just wish they could make such great progress for triple negatove

  • jo6359
    jo6359 Member Posts: 2,279
    edited July 2022

    I am her2+and hormone negative. I went through tchp plus double mastectomy and 27 radiation treatments in 2018. I am four and a half years out from my initial diagnosis. I am doing great. I have a little neuropathy that I developed between chemo treatment four and five. These discussion forums kept me sane during that first year. There are a lot of ups and downs with treatment. Chemo knocks you on your ass. I work in home health and I had flexibility with my schedule which allowed me to continue to work throughout treatment. There were days it took everything I had just to put one foot in front of the other not just from the physiological changes occurring with my body but also that thing called chemo fog. My mental status was definitely out of kilter.Moth is always on top of things when it comes to breast cancer research. Moth thanks for always being so generous with your time. Hang in there girl. To the rest of you there is a light at the end of the tunnel. But damn it there are a lot of detours to reach the end of the road. Even though I'm doing great I can still remember how scary and difficult the whole process is.

  • Kimm992
    Kimm992 Member Posts: 135
    edited August 2022

    I'm still here after being diagnosed in 2015! Happy and healthy and loving life!

Categories